Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis

Annals of Saudi Medicine

Volumn 29, Issue 6, 2009, Pages 454-459

  Alhamad, Esam H ^a   Alanezi, Mohammed O ^b   Idrees, Majdy M ^c   Chaudhry, Mohammad K ^a   AlShahrani, Ali M ^a   Isnani, Arthur ^d   Shaikh, Shaffi ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^d Department of Medicine   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; METHOTREXATE; OXYGEN;

ADULT; ARAB; ARTICLE; BRONCHIECTASIS; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC VALUE; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG SARCOIDOSIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WEIGHT REDUCTION;

ADULT; AGED; ARABS; BRONCHIECTASIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 70350686600     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.4103/0256-4947.57168     Document Type: Article

References (33)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736-755
2. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, et al. Clinical characteristics of patients in a case control study ofsarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885-1889 (Pubitemid 33152325)
3. James DG, Neville E, Siltzbach LE. A worldwide review of sarcoidosis. Ann N Y Acad Sci. 1976;278:321-334
4. Pietinalho A, Hiraga Y, Hosoda Y, Lofroos AB, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis. 1995;12(1):61-67
5. Pietinalho A, Ohmichi M, Hiraga Y, Lofroos AB, Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13(2):159-166
6. Behbehani N, JayKrishnan B, Khadadah M, Hawa H, Farah Y. Clinical presentation of sarcoidosis in a mixed population in the middle east. Respir Med. 2007;101(11):2284-2288 (Pubitemid 47471408)
7. Khan J, Dossing M, von Sinner WN, Bazarbashi M, Curley W. Sarcoidosis in native Saudis. Sarcoidosis. 1993;10(1):50-55
8. Samman Y, Ibrahim M, Wali S. Sarcoidosis in the western region of Saudi Arabia. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):215-218 (Pubitemid 29469103)
9. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J. 1961;2(5261):1165-1172
10. Austin JH, Muller NL, Friedman PJ, Hansell DM, Naidich DP, Remy-Jardin M, Webb WR, Zerhouni EA. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiol. 1996;200(2):327-331 (Pubitemid 26249879)
11. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(1):75-86.
12. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107-1136
13. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2185-2198
14. Milman N, Selroos O: Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis. 1990;7(2):113-118
15. Chevalet P, Clement R, Rodat O, Moreau A, Brisseau JM, Clarke JP: Sarcoidosis diagnosed in elderly subjects: retrospective study of 30 cases. Chest. 2004;126(5):1423-1430 (Pubitemid 39525012)
16. Lenner R, Schilero GJ, Padilla ML, Teirstein AS. Sarcoidosis presenting in patients older than 50 years. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(2):143-147 (Pubitemid 34685914)
17. Stadnyk AN, Rubinstein I, Grossman RF, Baum GL, Hiss Y, Solomon A, Rosenthal T. Clinical features of sarcoidosis in elderly patients. Sarcoidosis. 1988;5(2):121-123
18. Baughman RP, Iannuzzi MC, Lower EE, Moller DR, Balkissoon RC, Winget DB, Judson MA. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(3):198-204.
19. Baughman RP, Winget DB, Bowen EH, Lower EE. Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14(2):154-158 (Pubitemid 27427348)
20. Mana J, Salazar A, Pujol R, Manresa F. Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis? Respiration 1996;63(5):298-303.
21. Viskum K, Vestbo J. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J. 1993;6(3):349-353 (Pubitemid 23114879)
22. Finkel R, Teirstein AS, Levine R, Brown LK, Miller A. Pulmonary function tests, serum angiotensin-converting enzyme levels and clinical findings as prognostic indicators in sarcoidosis. Ann N Y Acad Sci. 1986;465:665-671 (Pubitemid 16006606)
23. Lieberman J, Schleissner LA, Nosal A, Sastre A, Mishkin FS. Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function. Chest. 1983;84(5):522-528
24. Shorr AF, Davies DB, Nathan SD. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest. 2003;124(3):922-928 (Pubitemid 37123310)
25. Sider L, Horton ES Jr. Hilar and mediastinal adenopathy in sarcoidosis as detected by computed tomography. J Thorac Imaging. 1990;5(2):77-80. (Pubitemid 20320099)
26. Muller NL, Mawson JB, Mathieson JR, Abboud R, Ostrow DN, Champion P. Sarcoidosis: correlation of extent of disease at CT with clinical, functional and radiographic findings. Radiol. 1989;171(3):613-618 (Pubitemid 19134907)
27. Hansell DM, Milne DG, Wilsher ML, Wells AU. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiol. 1998;209(3):697-704.
28. Handa T, Nagai S, Fushimi Y, Miki S, Ohta K, Niimi A, Mishima M, Izumi T. Clinical and radiographic indices associated with airflow limitation in patients with sarcoidosis. Chest. 2006;130(6):1851-1856 (Pubitemid 46033445)
29. Davies CW, Tasker AD, Padley SP, Davies RJ, Gleeson FV. Air trapping in sarcoidosis on computed tomography: correlation with lung function. Clin Radiol. 2000;55(3):217-221 (Pubitemid 30162579)
30. Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis. CT patterns and correlation with pulmonary function. AJR Am J Roentgenol. 2000;174(6):1751-1757 (Pubitemid 30346752)
31. Mana J, Teirstein AS, Mendelson DS, Padilla ML, DePalo LR. Excessive thoracic computed tomographic scanning in sarcoidosis. Thorax. 1995;50(12):1264-1266
32. Akira M, Kozuka T, Inoue Y, Sakatani M. Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest. 2005;127(1):185-191 (Pubitemid 41724575)
33. Murdoch J, Muller NL: Pulmonary sarcoidosis: changes on follow-up CT examination. AJR Am J Roentgenol. 1992;159(3):473-477